Interventions for vitiligo

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 2, 2015, Pages

  Whitton, Maxine E ^a   Pinart, Mariona ^b   Batchelor, Jonathan ^a   Leonardi Bee, Jo ^a   González, Urbà ^c   Jiyad, Zainab ^d   Eleftheriadou, Viktoria ^a   Ezzedine, Khaled ^e  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^c Unit of Dermatology   (Spain)

^d ST GEORGE S HOSPITAL   (United Kingdom)

^e HÔPITAL SAINT ANDRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AZATHIOPRINE; CALCIPOTRIOL; CLOBETASOL PROPIONATE; CORTICOSTEROID; GINKGO BILOBA EXTRACT; HYDROCORTISONE; HYDROCORTISONE BUTYRATE; METHOXSALEN; MOMETASONE FUROATE; PIMECROLIMUS; PLACEBO; PREDNISOLONE; PSORALEN; TACALCITOL; TACROLIMUS; TETRAHYDROCURCUMINOID; UNCLASSIFIED DRUG; PHOTOSENSITIZING AGENT; PLANT EXTRACT; STEROID;

ACNE; ADVERSE EVENT; BURN; BURNING SENSATION; CLINICAL OUTCOME; CONTACT DERMATITIS; ERYTHEMA; EVIDENCE BASED MEDICINE; FOLLICULITIS; FOLLOW UP; GINKGO BILOBA; HEADACHE; HOT FLUSH; HUMAN; INTERMETHOD COMPARISON; LIP DISEASE; META ANALYSIS; MYALGIA; NAUSEA; PAPULE; PHOTOTHERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; PRURITUS; PSYCHOTHERAPY; PUVA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; SKIN ATROPHY; SKIN EXFOLIATION; SKIN PIGMENTATION; SPLIT THICKNESS SKIN GRAFT; SUNLIGHT; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TELANGIECTASIA; THERAPY EFFECT; ULTRAVIOLET B RADIATION; VITILIGO; EXCIMER LASER; MULTIMODALITY CANCER THERAPY; PROCEDURES; SKIN TRANSPLANTATION; THERAPEUTIC USE;

COMBINED MODALITY THERAPY; GINKGO BILOBA; HUMANS; LASERS, EXCIMER; PHOTOSENSITIZING AGENTS; PHOTOTHERAPY; PLANT EXTRACTS; PUVA THERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SKIN PIGMENTATION; SKIN TRANSPLANTATION; STEROIDS; VITILIGO;

EID: 84965190922     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD003263.pub5     Document Type: Review

References (254)

1. Agarwal S, Ramam M, Sharma VK, Khandpur S, Pal H, Pandey RM. A randomised placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo. British Journal of Dermatology 2005;153(1):163-6. [MEDLINE: 16029343]
2. Akdeniz N, Yavuz IH, Bilgili SG, Ozayvin Yavuz G, Calca O. Efficacy of Narrow Band UVB alone, combination of Calcipotriol-Narrow Band UVB, and combination Betamethasone-Calcipotriol- Narrow Band UVB therapies in vitiligo. Journal of Dermatological Treatment 2013 May 6 [Epub ahead of print].
3. Akdeniz N, Yavuz IH, Gunes Bilgili S, Ozaydin Yavuz G, Calka O. Comparison of efficacy of narrow band UVB therapies with UVB alone, in combination with calcipotriol, and with betamethasone and calcipotriol in vitiligo. Journal of Dermatological Treatment 2014;25(3):196-9. [MEDLINE: 23441902]
4. Akhyani M, Hallaji Z, Ehsani AH, Mokarrami T, Gorouhi F. A comparison between systemic PUVA therapy alone and combined with topical calcipotriol in the treatment of generalized vitiligo. Iranian Journal of Dermatology 2005;8(3):48.
5. Anbar TS, Westerhof W, Abdel-Rahman AT, Ewis AA, El-Khayyat MA. Effect of one session of ER:YAG laser ablation plus topical 5Fluorouracil on the outcome of short-term NB-UVB phototherapy in the treatment of non-segmental vitiligo: A left-right comparative study. Photodermatology, Photoimmunology & Photomedicine 2008;24(6):322-9. [MEDLINE: 19000191]
6. Arca E, Tastan HB, Erbil AH, Sezer E, Koc E, Kurumlu Z. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo. Journal of Dermatology 2006;33(5):338-43. [MEDLINE: 16700666]
7. Asawanonda P, Kijluakiyat J, Korkij W, Sindhupak W. Targeted broadband ultraviolet B phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: A randomised, double-blind study. Acta Dermato-Venereologica 2008;88(4):376-81. [MEDLINE: 18709309]
8. Asawanonda P, Klahan SO. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study. Photomedicine & Laser Surgery 2010;28(5):679-84. [MEDLINE: 20961233]
9. Bakis-Petsoglou S, Le Guay JL, Wittal R. A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo. British Journal of Dermatology 2009;161(4):910-7. [MEDLINE: 19523170]
10. Bansal S, Sahoo B, Gaarg V. Psoralen-narrowband UVB phototherapy in treatment of vitiligo in comparison to narrowband UVB alone. Photodermatology, Photoimmunology & Photomedicine 2013; Vol. 29, issue 6:311-7. [MEDLINE: 24118425]
11. Barman KD, Khaitan BK, Verma KK. A comparative study of punch grafting followed by topical corticosteroid versus punch grafting followed by PUVA therapy in stable vitiligo. Dermatologic Surgery 2004;30(1):49-53. [MEDLINE: 14692927]
12. Bayoumi W, Fontas E, Sillard L, Le Duff F, Ortonne JP, Bahadoran P, et al. Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localizations. British Journal of Dermatology 2012;166(1):208-11. [MEDLINE: 21824124]
13. Bhatnagar A, Kanwar AJ, Parsad D, De D. Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: An open prospective study. Journal of the European Academy of Dermatology & Venereology 2007;21(5):638-42. [MEDLINE: 17447977]
14. Budania A, Parsad D, Kanwar AJ, Dogra S. Comparison between autologous non cultured epidermal cell suspension and suction blister epidermal grafting in stable vitiligo: a randomized study. British Journal of Dermatology 2012;167(6):1295-301. [MEDLINE: 22897617]
15. Budania A, Parsad D, Kanwar AJ, Dogra S. Comparison between autologous non-cultured epidermal cell suspension and suction blister epidermal grafting in stable vitiligo: A randomized study. 21st International Pigment Cell Conference, IPCC 2011, Bordeaux, France. Conference start: 20110920 Conference End: 20110924. Pigment Cell & Melanoma Research 2011;24(4):834. [EMBASE: 71001651]
16. Casacci M, Thomas P, Pacifico A, Bonnevalle A, Paro Vidolin A, Leone G. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo - A multi-centre controlled study. Journal of the European Academy of Dermatology & Venereology 2007;21(7):956-63. [MEDLINE: 17659006]
17. Cestari TF, Correia R, Dias MCS, Albaneze R, Fernandes E. Comparative study of two psoralens in topical phototherapy for vitiligo [Estudo comparativo entre dois psoralenos na fototerapia topica do vitiligo]. Anais Brasileiros de Dermatologia 2001;76(6):683-92. [EMBASE: 2002077177]
18. Czajkowski R. Comparison of melanocytes transplantation methods for the treatment of vitiligo. Dermatologic Surgery 2004;30(11):1400-5. [MEDLINE: 15522021]
19. Dawid M, Veensalu M, Grassberger M, Wolff K. Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: Results of a randomized, double-blind, vehicle-controlled study [Wirksamkeit und Sicherheit von Pimecrolimus-Creme 1% bei erwachsenen Patienten mit Vitiligo: Ergebnisse einer randomisierten, Vehikel-kontrollierten Doppelblind-Studie]. Journal der Deutschen Dermatologischen Gesellschaft. Journal of the German Society of Dermatology 2006;4(11):942-6. [MEDLINE: 17081269]
20. Dell'Anna ML, Mastrofrancesco A, Sala R, Venturini M, Ottaviani M, Vidolin AP, et al. Antioxidants and narrow band UVB in the treatment of vitiligo: a double-blind, placebo-controlled trial. Clinical & Experimental Dermatology 2007;32(6):631-6. [MEDLINE: 17953631]
21. de Macedo, AC, Oliveira CF, de SILVA ECM, de Andrade LAS. Application purposes of HeNe L.A.S.E.R.and ultraviolet B in vitiligo [Efeitos da aplicação do L.A.S.E.R. HeNe e do ultravioleta B no vitiligo]. Fisioterapia em Movimento 2012;25(3):481-8.
22. Elgoweini M, Nour El Din N. Response of vitiligo to narrowband ultraviolet B and oral antioxidants. Journal of Clinical Pharmacology 2009;49(7):852-5. [MEDLINE: 19553407]
23. El-Mofty M, Mostafa W, Youssef R, El-Fangary M, Elramly AZ, Mahgoub D, et al. Ultraviolet A in vitiligo. Photodermatology, Photoimmunology & Photomedicine 2006;22(4):214-6. [MEDLINE: 16869873]
24. El Mofty M, Mostafa W, Youssef R, El-Fangary M, El-Ramly A, Mahgoub D, et al. BB-UVA vs NB-UVB in the treatment of vitiligo: a randomized controlled clinical study (single blinded). Photodermatology, Photoimmunology & Photomedicine 2013;29(5):239-46. [MEDLINE: 24001379]
25. El Mofty M, Bosseila M, Mashaly HM, Gawdat H, Makaly H. Broadband ultraviolet A vs. psoralen ultraviolet A in the treatment of vitiligo: a randomized controlled trial. Clinical and Experimental Dermatology 2013;38(8):830-5. [MEDLINE: 23551324]
26. El-Zawahry BM, Bassiouny DA, Sobhi RM, Abdel-Aziz E, Zaki NS, Habib DF, et al. A comparative study on efficacy of UVA1 vs. narrow-band UVB phototherapy in the treatment of vitiligo. Photodermatology, Photoimmunology & Photomedicine 2012;28(2):84-90. [MEDLINE: 22409711]
27. Ermis O, Alpsoy E, Cetin L, Yilmaz E. Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study. British Journal of Dermatology 2001;145(3):472-5. [MEDLINE: 11531839]
28. Esfandiarpour I, Ekhlasi A, Farajzadeh S, Shamsadini S. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial. Journal of Dermatological Treatment 2009;20(1):14-8. [MEDLINE: 18608735]
29. Farah FS, Kurban AK, Chaglassian HT. The treatment of vitiligo with psoralens and triamcinolone by mouth. British Journal of Dermatology 1967;79(2):89-91. [MEDLINE: 6018207]
30. Farajzadeh S, Daraei Z, Esfandiarpour I, Hosseini SH. The efficacy of pimecrolimus 1% cream combined with microdermabrasion in the treatment of non-segmental childhood vitiligo: A randomized placebo-controlled study. Pediatric Dermatology 2009;26(3):286-91. [MEDLINE: 19706089]
31. Galarza C, Ramos W, Gutierrez EL, Oré R, Chía H, Ávila J, et al. Efficacy and security of topical antioxidant therapy versus placebo in the treatment of vitiligo of recent onset [Eficacia y seguridad de la terapia tópica antioxidante versus placebo en el tratamiento del vitíligo generalizado de reciente inicio]. Dermatología Peruana 2009;19:198-204.
32. Ghosh D, Kuchroo P, Viswanathan C, Sachan S, Shah B, Bhatt D, et al. Efficacy and safety of autologous cultured melanocytes delivered on poly (DL-lactic acid) film: a prospective, open-label, randomized, multicenter study. Dermatologic Surgery 2012;38(12):1981-90. [MEDLINE: 23025333]
33. Goldinger SM, Dummer R, Schmid P, Burg G, Seifert B, Läuchli S. Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo. Journal of the European Academy of Dermatology & Venereology 2007;21(4):504-8. [MEDLINE: 17373978]
34. Hamzavi I, Jain H, McLean D, Shapiro J, Zeng H, Liu H. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. Archives of Dermatology 2004;140(6):677-83. [MEDLINE: 15210457]
35. Ho N, Pope E, Weinstein M, Greenberg S, Webster C, Krafchik BR. A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0.1% vs. clobetasol propionate 0.05% in childhood vitiligo. British Journal of Dermatology 2011;165(3):626-32. [MEDLINE: 21457214]
36. Hofer A, Hassan AS, Legat FJ, Kerl H, Wolf P. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients. British Journal of Dermatology 2005;152(5):981-5. [MEDLINE: 15888156]
37. Hui-Lan Y, Xiao-Yan H, Jian-Yong F, Zong-Rong L. Combination of 308-nm excimer laser with topical pimecrolimus for the treatment of childhood vitiligo. Pediatric Dermatology 2009;26(3):354-6. [MEDLINE: 19706108]
38. Kandil E. Treatment of vitiligo with 0.1% betamethasone 17-valerate in isopropyl alcohol - a double-blind trial. British Journal of Dermatology 1974;91(4):457-60. [MEDLINE: 4609450]
39. Kathuria S, Khaitan BK, Ramam M, Sharma VK. Segmental vitiligo: A randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream. Indian Journal of Dermatology, Venereology & Leprology 2012;78(1):68-73. [MEDLINE: 22199063]
40. Kawalek AZ, Spencer JM, Phelps RG. Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study. Dermatologic Surgery 2004;30(2 Pt 1):130-5. [MEDLINE: 14756638]
41. Khalid M, Mujtaba G, Haroon TS. Comparison of 0.05% clobetasol propionate cream and topical PUVAsol in childhood vitiligo. International Journal of Dermatology 1995;34(3):203-5. [MEDLINE: 7751099]
42. Khandpur S, Sharma VK, Manchanda Y. Comparison of minipunch grafting versus split-skin grafting in chronic stable vitiligo. Dermatologic Surgery 2005;31(4):436-41. [MEDLINE: 15871319]
43. Klahan S, Asawanonda P. Topical tacrolimus may enhance repigmentation with targeted narrowband ultraviolet B to treat vitiligo: a randomized, controlled study. Clinical & Experimental Dermatology 2009;34(8):e1029-30. [MEDLINE: 20055831]
44. Köse O, Arca E, Kurumlu Z. Mometasone cream versus pimecrolimus cream for the treatment of childhood localized vitiligo. Journal of Dermatological Treatment 2010;21(3):133-9. [MEDLINE: 20394489]
45. Kumaran MS, Kaur I, Kumar B. Effect of topical calcipotriol, betamethasone dipropionate and their contribution in the treatment of localized vitiligo. Journal of the European Academy of Dermatology & Venereology 2006;20(3):269-73. [MEDLINE: 16503885]
46. Le Duff F, Fontas E, Giacchero D, Sillard L, Lacour JP, Ortonne JP, et al. 308-nm excimer lamp vs. 308-nm excimer laser for treating vitiligo: a randomized study. British Journal of Dermatology 2010;163(1):188-92. [MEDLINE: 20346025]
47. Leone G, Pacifico A, Iacovelli P, Paro Vidolin A, Picardo M. Tacalcitol and narrow-band phototherapy in patients with vitiligo. Clinical & Experimental Dermatology 2006;31(2):200-5. [MEDLINE: 16487090]
48. Lepe V, Moncada B, Castanedo-Cazares JP, Torres-Alvarez MB, Ortiz CA, Torres-Rubalcava AB. A double-blind randomised trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Archives of Dermatology 2003;139(5):581-5. [MEDLINE: 12756094]
49. Lim-Ong M, Leveriza RMS, Ong BET, Frez MLF. Comparison between narrow-band UVB with topical corticosteroid and narrow-band UVB with placebo in the treatment of vitiligo: A randomized controlled trial. Journal of the Phillipine Dermatological Society 2005;14:17-25.
50. Linthorst Homan MW, Spuls PI, Nieuweboer-Krobotova L, de Korte J, Sprangers MA, Bos JD, et al. A randomized comparison of excimer laser versus narrow-band ultraviolet B phototherapy after punch grafting in stable vitiligo patients. Journal of the European Academy of Dermatology & Venereology 2012;26(6):690-5. [MEDLINE: 21711467]
51. Lu-yan T, Wen-wen F, Lei-hong X, Yi J, Zhi-zhong Z. Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo. Photodermatology, Photoimmunology & Photomedicine 2006;22(6):310-4. [MEDLINE: 17100739]
52. Mehrabi D, Pandya A. A randomized, placebo-controlled, double-blind trial comparing narrowband UVB plus tacrolimus 0.1% ointment vs narrowband UVB pls placebo ointment in the treatment of generalized vitiligo; 2005 63rd Annual Meeting of the American Academy of Dermatology. Journal of the American Academy of Dermatology 2005;52(Suppl):P167.
53. Mehrabi D, Pandya AG. A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo. Archives of Dermatology 2006;142(7):927-9. [MEDLINE: 16847214]
54. Middelkamp-Hup MA, Bos JD, Rius-Diaz F, Gonzalez S, Westerhof W. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study. Journal of the European Academy of Dermatology & Venereology 2007;21(7):942-50. [MEDLINE: 17659004]
55. Mohaghegh F, Asilian A, Faghihi G, Adibi N. A comparison between the efficacy of narrow band ultra violet B phototherapy with and without needling of the lesion in the treatment of vitiligo. Journal of Research in Medical Sciences 2012;17(1 Suppl 1):S131-133. [EMBASE: 2013471633]
56. Navarro JR, Canales AA, Salado Ponce H, el al. Autologous skin minigraft and ingestion of 8-methoxypsoralen in patients with stable vitiligo vulgaris. Dermatologia Revista Mexicana 2002;46:260-7.
57. Nistico S, Chiricozzi A, Saraceno R, Schipani C, Chimenti S. Vitiligo treatment with monochromatic excimer light and tacrolimus: results of an open randomized controlled study. Photomedicine & Laser Surgery 2012;30(1):26-30. [MEDLINE: 22054204]
58. Nordal EJ, Guleng GE, Ronnevig JR. Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right/left double-blind comparative study. Journal of the European Academy of Dermatology & Venereology 2011;25(12):1440-3. [MEDLINE: 21466589]
59. Oh SH, Kim T, Jee H, Do JE, Lee JH. Combination treatment of non-segmental vitiligo with a 308-nm xenon chloride excimer laser and topical high-concentration tacalcitol: a prospective, single-blinded, paired, comparative study. Journal of the American Academy of Dermatology 2011;65(2):428-30. [MEDLINE: 21763570]
60. Ozdemir M, Cetinkale O, Wolf R, Kotogyan A, Mat C, Tüzün B, et al. Comparison of two surgical approaches for treating vitiligo: a preliminary study. International Journal of Dermatology 2002;41(3):135-8. [MEDLINE: 12010337]
61. Papadopoulos L, Walker C, Anthis L. Living with vitiligo: A controlled investigation into the effects of group cognitive-behavioural and humanistic therapies. Dermatology & Psychosomatics 2004;5(4):172-7. [DOI: ]
62. Paracha MM, Khurshid K, Pal SS, Zafar A. Comparison of treatment with tacrolimus 0.03% and superoxide dismutase and catalase in vitiligo. Journal of Postgraduate Medical Institute 2010;24(2):115-21.
63. Parsad D, Saini R, Verma N. Combination of PUVAsol and topical calcipotriol in vitiligo. Dermatology 1998;197(2):167-70. [MEDLINE: 9732168]
64. Parsad D, Pandhi R, Juneja A. Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo. Clinical & Experimental Dermatology 2003;28(3):285-7. [MEDLINE: 12780716]
65. Passeron T, Ostovari N, Zakaria W, Fontas E, Larrouy JC, Lacour JP, et al. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. Archives of Dermatology 2004;140(9):1065-9. [MEDLINE: 15381545]
66. Pathak MA, Mosher DB, Fitzpatrick TB. Safety and therapeutic effectiveness of 8-methoxypsoralen, 4, 5', 8-trimethylpsoralen, and psoralen in vitiligo. National Cancer Institute Monograph 1984;66:165-73. [MEDLINE: 6531024]
67. Procaccini EM, Riccio G, Monfrecola G. Ineffectiveness of topical khellin in photochemotherapy of vitiligo. Journal of Dermatological Treatment 1995;6(2):117-20. [EMBASE: 1995218202]
68. Radakovic S, Breier-Maly J, Konschitzky R, Kittler H, Sator P, Hoenigsmann H, et al. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial. Journal of European Academy of Dermatology & Venereology 2009;23(8):951-3. [MEDLINE: 19496898]
69. Radmanesh M, Saedi K. The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients. Journal of Dermatological Treatment 2006;17(3):151-3. [MEDLINE: 16854754]
70. Rath N, Kar HK, Sabhnani S. An open labelled, comparative clinical study on efficacy and tolerability of oral minipulse of steroid (OMP) alone, OMP with PUVA and broad/narrow band UVB phototherapy in progressive vitiligo. Indian Journal of Dermatology, Venereology & Leprology 2008;74(4):357-60. [MEDLINE: 18797057]
71. Reyes E, Jaén P, de las Heras E, Carrión F, Alvarez-Mon M, de Eusebio E, et al. Systematic immunomodulatory effects of Polypodium leucotomos as an adjuvant to PUVA therapy in generalized vitiligo: A pilot study. Journal of Dermatological Science 2006;41(3):213-6. [MEDLINE: 16423508]
72. Rodriguez-Martin M, Bustinduy MG, Saez Rodriguez M, Noda Cabrera A. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo. British Journal of Dermatology 2009;160(2):409-14. [MEDLINE: 19016706]
73. Rojas-Urdaneta JE, Poleo-Romero AG. Evaluation of an antioxidant and mitochondria-stimulating cream formula in the skin of patients with stable common vitiligo [Evaluacion de una formlacion antioxidante y estimuladora mitocondrial en piel de pacientes con vitiligo vulgar estable]. Investigacion Clinica 2007;48(1):21-31. [MEDLINE: 17432541]
74. Ruiz-Maldonado R, Tamayo-Sanchez L. 4-5-8 trimethylpsoralen in vitiligo. Controlled study of its therapeutic and toxic effect in children [4-5-8 trimetilpsoralen en vitiligo. Estudio controlado de su efecto terapeutico y toxico en los ninos]. Actas Dermo-Sifiliograficas 1975;66(9-10):513-26. [MEDLINE: 1199825]
75. Sahni K, Parsad D, Kanwar AJ, Mehta SD. Autologous noncultured melanocyte transplantation for stable vitiligo: can suspending autologous melanocytes in the patients' own serum improve repigmentation and patient satisfaction?. Dermatologic Surgery 2011;37(2):176-82. [MEDLINE: 21269348]
76. Sanclemente G, Garcia JJ, Zuleta JJ, Diehl C, Correa C, Falabella R. A double-blind randomized trial of 0.05% betamethasone vs. topical catalase/dismutase superoxide in vitiligo. Journal of the European Academy of Dermatology & Venereology 2008;22(11):1359-64. [MEDLINE: 18624857]
77. Sapam R, Agrawal S, Dhali TK. Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study. International Journal of Dermatology 2012;51(9):1107-15. [MEDLINE: 22909369]
78. Sassi F, Cazzaniga S, Tessari G, Chatenoud L, Reseghetti A, Marchesi L, et al. Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck. British Journal of Dermatology 2008;159(5):1186-91. [MEDLINE: 18717675]
79. Satyanarayan HS, Kanwar AJ, Vinay K. Efficacy and tolerability of combined treatment with NB-UVB and topical tacrolimus versus NB-UVB alone in patients with vitiligo vulgaris: a randomized intra-individual open comparative trial. Indian Journal of Dermatology, Venereology & Leprology 2013;79(4):525-7. [MEDLINE: 23760325]
80. Schallreuter KU, Moore J, Behrens-Williams S, Panske A, Harari M. Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS). International Journal of Dermatology 2002;41(8):482-7. [MEDLINE: 12207762]
81. Sharquie KE, Abdulla MS. Treatment of vitiligo with topical 15% lactic acid solution in combination with ultra violet-A. Saudi Medical Journal 2005;26(6):1013-5. [MEDLINE: 15983698]
82. Sheth VM, Currimbhoy SD, Feetham HJ, Graves MS, Chan J, Hynan LS, et al. Efficacy of narrowband ultraviolet B versus excimer radiation in repigmenting vitiligo after minigrafting on the distal arms. Journal of the American Academy of Dermatology 2012;67(2):318-20. [MEDLINE: 22794808]
83. Shi N, Chen YJ, Wang J, Ni H. Clinical observation on the effect of Zengse pill in treating patients with vitiligo of Qi-stagnancy and blood-stasis syndrome type. Chinese Journal of Integrative Medicine 2008;14(4):303-6. [MEDLINE: 19082804]
84. Shi Q, Li K, Fu J, Wang Y, Ma C, Li Q, et al. Comparison of the 308-nm excimer laser with the 308-nm excimer lamp in the treatment of vitiligo--a randomized bilateral comparison study. Photodermatology, Photoimmunology & Photomedicine 2013;29(1):27-33. [MEDLINE: 23281694]
85. Shi Q, Li K, Li Q, Li C-Y, Gao T-W. Comparison between 308 nm excimer laser and 308 nm excimer lamp in the treatment of vitiligo: a randomized self-control study. Journal of Dermatology 2nd Eastern Asia Dermatology Congress Beijing China. 2012.
86. Shin J, Lee JS, Hann SK, Oh SH. Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study. British Journal of Dermatology 2012;166(3):658-61. [MEDLINE: 22050270]
87. Siddiqui AH, Stolk LM, Bhaggoe R, Hu R, Schutgens RB, Westerhof W. L-phenylalanine and UVA irradiation in the treatment of vitiligo. Dermatology 1994;188(3):215-8. [MEDLINE: 8186511]
88. Singh C, Parsad D, Kanwar AJ, Dogra S, Kumar R. Comparison between autologus noncultured extracted hair follicle outer root sheath cell suspension and autologous noncultured epidermal cell suspension in the treatment of stable vitiligo: a randomized study. British Journal of Dermatology 2013;169(2):287-93. [MEDLINE: 23517382]
89. Souto MG, Manhaes AMH, Milhomens CH, Succi ICB. Comparative study between melagenina and placebo in the treatment of vitiligo [Estudio comparativo entre melagenina e placebo no tratamento do vitiligo]. Anais Brasileiros de Dermatologia 1997;72(3):237-9. [EMBASE: 1997206939]
90. Stinco G, Piccirillo F, Forcione M, Valent F, Patrone P. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo. European Journal of Dermatology 2009;19(6):588-93. [MEDLINE: 19651562]
91. Tegta GR, Parsad D, Majumdar S, Kumar B. Efficacy of autologous transplantation of noncultured epidermal suspension in two different dilutions in the treatment of vitiligo. International Journal of Dermatology 2006;45(2):106-10. [MEDLINE: 16445497]
92. Tjioe M, Gerritsen MJ, Juhlin L, van de Kerkhof PC. Treatment of vitiligo vulgaris with narrowband UVB (311nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Dermato-Venereologica 2002;82(5):369-72. [MEDLINE: 12430737]
93. van Geel N, Ongenae K, De Mil M, Haeghen YV, Vervaet C, Naeyaert JM. Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo. Archives of Dermatology 2004;140(10):1203-8. [MEDLINE: 15492182]
94. Vasistha LK, Singh G. Vitiligo and intralesional steroids. Indian Journal of Medical Research 1979;69:308-11. [PUBMED: 429039]
95. Verhaeghe E, Lodewick E, van Geel N, Lambert J. Intrapatient comparison of 308-nm monochromatic excimer light and localized narrow-band UVB phototherapy in the treatment of vitiligo: a randomized controlled trial. Dermatology 2011;223(4):343-8. [MEDLINE: 22269666]
96. Wazir SM, Paracha MM, Khan SU. Efficacy and safety of topical mometasone furoate 0.01% vs. tacrolimus 0.03% and mometasone furoate 0.01% in vitiligo. Journal of Pakistan Association of Dermatologists 2010;20(2):89-92. [EMBASE: 2010454952]
97. Westerhof W, Nieuweboer-Krobotova L, Mulder PG, Glazenburg EJ. Left-right comparison study of the combination of fluticasone propionate and UVA vs either fluticasone propionate or UVA alone for the long-term treatment of vitiligo. Archives of Dermatology 1999;135(9):1061-6. [MEDLINE: 10490110]
98. Wind BS, Meesters AA, Kroon MW, Beek JF, van der Veen JP, Nieuweboer-Krobotova L, et al. Punchgraft testing in vitiligo; effects of UVA, NB-UVB and 632.8 nm Helium-Neon laser on the outcome. Journal of the European Academy of Dermatology & Venereology 2011;25(10):1236-7. [MEDLINE: 21039919]
99. Yaghoobi R, Omidian M, Bagherani N. Comparison of therapeutic efficacy of topical corticosteroid and oral zinc sulfate-topical corticosteroid combination in the treatment of vitiligo patients: a clinical trial. BMC Dermatology 2011;11:7. [MEDLINE: 21453467]
100. Yones SS, Palmer RA, Garibaldinos TM, Hawk JL. Randomized double blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy. Archives of Dermatology 2007;143(5):578-84. [MEDLINE: 17519217]
101. Yones SS, Palmer RA, Garibaldinos TM, Hawk JLM. A prospective randomised double blind trial of the efficacy of narrow-band UVB (TL01) phototherapy and psoralen photochemotherapy(PUVA) in the treatment of vitiligo [10]. 15th Annual Meeting of the Photomedicine Society, San Francisco, California, USA, March 2, 2006. Photodermatology, Photoimmunology & Photomedicine 2006;22(4):223. [DOI: ]
102. Babu A, Thappa DM, Jaisankar TJ. Punch grafting versus suction blister epidermal grafting in the treatment of stable lip vitiligo. Dermatologic Surgery 2008;34(2):166-78. [MEDLINE: 18093203]
103. Bahmani M, Fallahzadeh MK, Jowkar F, Khalesi M, Bahri-Najafi R, Namazi MR. Can topical phenytoin augment the therapeutic efficacy of PUVA against vitiligo? A double-blind, randomized, bilateral-comparison, placebo-controlled study. Journal of Dermatological Treatment 2011;22(2):106-8. [MEDLINE: 20443664]
104. Du RM. Treating vitiligo with integrated traditional chinese and western medicine in 232 cases. Journal of Shanxi College of Traditional Chinese Medicine [Shan Xi Zhong Yi Xue Yuan Xue Bao] 1996;12(3):22-3.
105. El Mofty ME, Zaher H, Esmat S, Youssef R, Bassioni D, Enani GE. PUVA and PUVB in vitiligo - Are they equally effective?. Photodermatology, Photoimmunology & Photomedicine 2001;17(4):159-63. [MEDLINE: 11499536]
106. El Mofty M, Mostafa W, Esmat S, Youssef R, Azzam O, Hunter N, et al. Narrow band Ultraviolet B 311 nm in the treatment of vitiligo: Two right-left comparison studies. Photodermatology, Photoimmunology & Photomedicine 2006;22(1):6-11. [MEDLINE: 16436175]
107. El Zawahry M, Soliman M, El Ansary M, El Zawahry MB, Aziz EA, Rady M. A clinical and immunological study of the effect of the different modalities of treatment on vitiligo patients. Journal of the Pan-Arab League of Dermatologists 1997;8:63-75.
108. Ghosh SK, Roy AK. Comparative evaluation of different regimens in the treatment of vitiligo. Indian Journal of Dermatology 1994;39(4):69-72.
109. Godse KV. Comparison of two diluents of 1% methoxsalen in the treatment of vitiligo. Indian Journal of Dermatology, Venereology & Leprology 2008;74(3):298. [MEDLINE: 18597981]
110. Shi QC. Clinical observation on effect of Quan Xiao Wan plus Decocton ¢ó for vitiligo. Jiangsu Journal of Traditional Chinese Medicine [Jiang Su Zhong Yi] 1995;16(7):24.
111. Sun BY. Clinical observation on effect of Bai Dian Ling Ding for leucoderma in 107 cases. Jiangsu Journal of Traditional Chinese Medicine [Jiang Su Zhong Yi] 1996;17(9):19-20.
112. Suo DF, Zhang JL, Yan CY. Combination of topical tacrolimus ointment and NB-UVB for vitiligo on the face and neck. Journal of Clinical Dermatology 2010;39(2):127-9. [EMBASE: 2010219716]
113. Xu RZ. Clinical observation on the effect of Drug Cupping Therapy in treating Vitiligo. Zhongguo zhen jiu [Chinese acupuncture & moxibustion] 1992;12(3):11-2.
114. Zhang AP. Autologous epidermal grafting combined with small dose corticosteroids in treating progressive stage vitiligo in 10 cases. Modern Journal of Integrated Traditional Chinese and Western Medicine [Xian Dai Zhong Xi Yi Jie He Za Zhi] 2008;17(7):1024.
115. Al Rubaie S. An open randomized study of treatment of 339 patients of generalized vitiligo with narrow band versus topical calcipotriol + PUVA versus PUVA therapy for 6 - 12 months. 11th Congress of the European Academy of Dermatology and Venereology. Journal of the European Academy of Dermatology & Venereology. 2002; Vol. 16, issue Suppl s1.
116. Awasthi S, Kanwar AJ, Parsad D. Comparing the effect on the outcome of cold trypsinisation versus warm trypsinisation in transplantation of autologous non-cultured epidermal cell suspension in stable vitiligo - a prospective randomized study. 21st International Pigment Cell Conference IPCC. Pigment Cell & Melanoma Research 2011;24(4):796. [EMBASE: 71001524]
117. Baldo A, Lodi G, Di Caterino P, Monfrercola G. Vitiligo, NB-UVB and tacrolimus: our experience in Naples. Giornale Italiano di Dermatologia e Venereologia 2014;149(1):123-30. [MEDLINE: 24566573]
118. Budania A, Parsad D, Dogra S, Khunger N. A randomized comparative study between autologous noncultured epidermal cell suspension, suction blister epidermal grafting and splitthickness skin grafting: A quest to find a first-line surgical modality for the treatment of stable vitiligo. 94th Annual Meeting of the British Association of Dermatologists Glasgow United Kingdom. British Journal of Dermatologists conference publication. 2014.
119. Caballero A, Jurado F, Luisa MP, Solano G. Combined treatment with clobetasol and cognitive behavioral therapy in adult patients with vitiligo. 41st Annual Meeting of the European Society for Dermatological Rsearch (ESDR). Journal of Investigative Dermatology 2011;131(Suppl 2):S114.
120. Daniel BS, Venugopal SS, Martin LK, Agero AL, Rhodes LM, Frew JW, et al. A randomised controlled trial assessing the effectiveness of minigrafting versus ReCell in stable vitiligo: Preliminary results. 21st International Pigment Conference IPCC. Pigment Cell & Melanoma Research 2011;24(4):834-5. [EMBASE: 71001653]
121. de la Fuente-Garcia A, Gomez-Flores M, Mancillas-Adame L, Ocampo-Candiani J, Welsh-Lozano O, Perez JZ, et al. Role of the ACTH test and estimation of a safe dose for high potency steroids in vitiligo: A prospective randomized study. Indian Dermatology Online Journal 2014;5(2):117-21. [MEDLINE: 24860741]
122. de Leeuw J, Assen YJ, van der Beek N, Bjerring P, Martino Neumann HA. Treatment of vitiligo with khellin liposomes, ultraviolet light and blister roof transplantation. Journal of the European Academy of Venereology & Dermatology 2011;25(1):74-81. [MEDLINE: 20477914]
123. Ediriweera ERHSS, Kalawana OTMRKSB, Karunarathna N, Nanayakkara NGAAS. Clinical study on efficacy of the traditional sri lankan oil 'the kakodumbaradi taila' with selected ayurvedic preparations on shvitra (vitiligo). AYU 2009;30(3):225-31. [: http://ayurveduniversity.edu.in/newsletters/ayu/2009_3/30302.pdf]
124. Eleftheriadou V, Thomas K, Ravenscroft J, Whitton M, Batchelor J, Williams H. Feasibility, double-blind, randomised, placebo-controlled, multi-centre trial of hand-held NB-UVB phototherapy for the treatment of vitiligo at home (HI-Light trial: Home Intervention of Light therapy). Trials 2014;15:51. [PUBMED: 24507484]
125. Fatemi-Naeini F, Vaez-Shooshtari A, Ebrahimi B, Nilforoushzadeh MA, Molaei R. The effect of pseudocatalase/superoxide dismutase in treatment of vitiligo: A pilot study. Journal of Isfahan Medical School 2014;31(269 Spec Issue):2309-14. [EMBASE: 2014574595]
126. Ghorbanibirgani A, Khalili A, Rokhafrooz D. Comparing nigella sativa oil and fish oil in treatment of vitiligo. Iranian Red Crescent Medical Journal 2014;16(6):not provided. [EMBASE: 2014405707]
127. Gimenez-Azcarate A, Bernad I, Irrazaval I, Lera M, Redondo P. Double-blind, randomized, intraindividually controlled clinical trial to evaluate the efficacy of autologous melanocyte cell transplant using amniotic membrane as a scaffold in the treatment of stable vitiligo. 71st Annual Meeting of the American Academy of Dermatology. Journal of the American Academy of Dermatology 2013;68(4 Suppl 1):AB189. [EMBASE: 70997838]
128. Kalafi A, Jowkar F. Evaluation of the efficacy of topical tetracycline in enhancing the effect of Narrow Band UVB against vitiligo: a double blind, randomized, placebo-controlled trial. ISRN Dermatology 2014;2014:472546. [EMBASE: 2014186713]
129. Li C, Fu J, Wang Y, Cuiling M, Tianwen G. 308nm excimer light vs308nm excimer laser fro treating vitiligo: A randomized study. Journal of Dermatology. 1st Eastern Asia Dermatology Congress EADC. Fukuoka, Japan, 2010.
130. Martin L, Wittal R, Murrell DF, Le Guay, J. Randomised controlled trial of minigrafting versus recell in stable vitiligo. Journal of Investigative Dermatology. Melbourne, Australia: 3rd Annual Meeting of the Australasian Society for Dermatology Research, 2007; Vol. 127:2685-2685.
131. Naini FF, Shooshtari AV, Ebrahimi B, Molaei R. The effect of pseudocatalase/superoxide dismutase in the treatment of vitiligo: A pilot study. Journal of Research in Pharmacy Practice 2012;1(2):77-80. [EMBASE: 2013680769]
132. Nitayavardhana S, Wongpraparut C, Thanomkitti K, Silpa-Archa N. Comparison of efficacy and safety of 0.1%tacrolimus ointment and 0.1% mometasone furoate cream for adult vilitigo: A single-blind pilot study. 72nd Annual Meeting of the American Academy of Dermatology, Denver, USA. Conference Start: 20140321 Conference End: 20140325. Journal of the American Academy of Dermatology 2014;70(5 Suppl 1):AB159. [EMBASE: 71390721]
133. Pacifico A, Vidolin AP, Leone G, Lacovelli P. Combined treatment of narrowband ultraviolet light B (NBUVB) phototherapy and oral polypodium leucotomos extract versus NBUVB phototherapy alone in the treatment of patients with vitiligo. Journal of the American Academy of Dermatology: 67th Annual Meeting of the American Academy of Dermatology 2009;60(3):AB154.
134. Passeron T, Bayoumi W, Le Duff F, Sillard L, Lacour J-P, Ortonne J-P. Erbium laser dermabrasion for treating vitiligo: a combination approach. 31st Annual Conference of the American Society for Laser Medicine and Surgery, TX United States. Lasers in Surgery & Medicine 2011;43:944. [EMBASE: 70640254]
135. Phiske M, Patil B, Bharda Z, Jerajani H. Tacrolimus versus pimecrolimus in localised stable vitiligo. 21st International PIgment Cell Conference IPCC. Pigment Cell & Melanoma Research: 2011;24(4):833. [EMBASE: 71001647]
136. Ramaiah A, Kar K, Garg VK, Bajaj N, Madhava AS. Double blind randomised clinical trial of bFGF related deca peptide to treat vitiligo. 21st International Pigment Cell Conference IPCC. Pigment Cell & Melanoma Research. Bordeaux, France, 2011.
137. Rondon Lugo AJ, Weiss E, Perez RP, Fuenmajor ME, Rothe J, Bricano L, et al. Double blind comparative study between melagenina and placebo in the treatment of vitiligo [Estudio doble ciego comparativo entre melagenina y placebo en el tratamiento del vitiligo]. Dermatologia Venezolana 1987;25(3-4):45-8.
138. Seckin D, Eryilmaz A, Baba M. A double-blind randomized trial of 1% pimecrolimus versus 0.05% clobetasol propionate for the treatment of vitiligo. 65th Annual Meeting of the American Academy of Dermatology. Journal of the American Academy of Dermatology 2007;56(Suppl S):AB170.
139. Shah R, Hunt, J, Webb TL, Thompson R. Starting to develop self-help for social anxiety associated with vitiligo: using clinical significance to measure the potential effectiveness of enhanced psychological self-help. British Journal of Dermatology 2014 August 4 [Epub ahead of print]. [PUBMED: 24665869]
140. Singh A, Kanwar AJ, Parsad D, Mahajan R. Randomized controlled study to evaluate the effectiveness of dexamethasone oral minipulse therapy versus oral minocycline in patients with active vitiligo vulgaris. Indian Journal of Dermatology, Venereology & Leprology 2014;80(1):29-35. [PUBMED: 24448120]
141. Syed T, Bhakhri AK, Aly R, Wong W. Management of vitiligo with 5% polyphenone (-EGCg) in a hydrophilic cream. A placebo-controlled, double-blind study. 64th Annual Meeting of the American Academy of Dermatology. Journal of the American Academy of Dermatology 2006;54(Suppl S):AB196.
142. Verma R, Grewal RS, Chatterjee M, Pragasam V, Vasudevan B, Mitra D. A comparative study of efficacy of cultured versus non cultured melanocyte transfer in the management of stable vitiligo. Medical Journal of the Armed Forces India 2014;70(1):26-31. [EMBASE: 2014322180]
143. Wu Y, Qiu L, Chen H-D, Gao X-H. A comparative study on efficacy of 308nm-excimer laser vs. Tacrolimus in the treatment of progressive vitiligo on face or neck. 27th International Congress Laser Medicine and IALMS Courses, Laser Florence 2013 Florence Italy. Conference Start: 20131109 Conference End: 20131110. Lasers in Medical Science 2013;28(6):1430. [EMBASE: 71280965]
144. Yan Y, Li J, Wang R, Zhong RP, Guo LH, Zhu MH. A randomised controlled trial for 308 nm excimer laser and narrow band ultraviolet B in the treatment of vitiligo. Journal of Clinical Dermatology 2013;42(2):120-3.
145. Zhang Y, Chen CT, Huang S, Zhou JW. Efficacy observation of fire needle combined with narrow band ultraviolet-B (NB-UVB) for vitiligo. Chinese Acupuncture & Moxibustion [Zhongguo zhen jiu] 2013;33(2):121-4. [EMBASE: 23620938]
146. Zhang DM, Hong WS, Fu LF, Wei XD, Xu AE. A randomized controlled study of the effects of different modalities of narrow-band ultraviolet B therapy on the outcome of cultured autologous melanocytes transplantation in treating vitiligo. Dermatologic Surgery 2014;40(4):420-6. [PUBMED: 24446755]
147. ACTRN12607000635460. The use of melanocyte/keratinocyte-suspension for the re-pigmentation of amelanotic patches in vitiligo. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12607000635460 (accessed 04.2013).
148. ACTRN12610000581066. A randomised controlled trial of Light Amplification by Stimulated Emission of Radiation (LASER) application and ultraviolet application on decreasing the area affected by vitiligo. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=335713 (accessed 10.2013).
149. Chictr-TRC-12002584. NB-UVB + placebo vs. NB-UVB + lipoic acid tablets for the treatment of the sporadic treatment quiescent vitiligo: efficacy and safety of the multi-center, randomized, double-blind, parallel-group clinical trials. www.chictr.org/en/proj/show.aspx?proj=3434 (accessed 04.2013).
150. Chictr-TRC-12002593. Dot matrix laser + betamethason compound injection / triamcinolone acetonide + NB-UVB vs dipropionate betamethasone cream + NB-UVB for the treatment of the acral type (including the subcarinal parts) of vitiligo: the efficacy and safety of the multi-center, open, randomized controlled clinical trials. www.chictr.org/en/proj/show.aspx?proj=3438 (accessed 04.2013).
151. ChiCTR-TRC-12002594. 308-nm excimer laser plus betamethasone compound Injection vs. tacrolimus ointment plus betamethason compound Injection for the treatment of advanced face and neck vitiligo: efficacy and safety of the multi-center, randomized, open, parallel, self-controlled clinical trials. www.chictr.org/en/proj/search.aspx?institution (accessed 04.2013).
152. ChiCTR-TRC-12002595. 308nm excimer laser vs tacrolimus ointment for the treatment of the stationary phase surface neck vitiligo: the efficacy and safety of multi-center, randomized, open, parallel, self-controlled clinical trials. www.chictr.org/en/proj/show.aspx?proj=3436 (accessed 04.2013).
153. ChiCTR-TRC-112002596. NB-UVB + lipoic acid tablets + compound times betamethasone injection vs. NB-UVB + placebo + compound betamethasone injection for the treatment of sporadic progress vitiligo: efficacy and safety of the multi-center, randomized, double-blind, parallel-group clinical trial. www.chictr.org/en/proj/show.aspx?proj=3435 (accessed 04.2013).
154. CTRI/2012/03/002531. Double-blind, randomized study to evaluate the ability of H-009 and arsenic-sulphuricum-flavum in stimulating pigmentation in vitiligo and examining safety in patients. www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4317 (accessed 04.2013).
155. CTRI/2012/11/003157. Pharmaceutical standardization of two different dosage form of Apamarg Kshara Yoga and their clinical efficacy on Shvitra (vitiligo}. www.who.int/trialsearch/trial.aspx?trialid=CTRI/2012/11/003157 (accessed 04.2013).
156. EUCTR2008-006903-22-NL. Narrow band UV-B phototherapy and fluticasone proprionate versus narrow band UV-B phototherapy and placebo for the treatment of active vitiligo: a randomized double blind controlled trial - UVBVIT. apps.who.int/trialsearch/trial.aspx?trialid=EUCTR2008-006903-22-NL (accessed 04.2013 ).
157. EUCTR2010-019994-13-FR. Exploratory study to evaluate the safety and efficacy of CD07387 solution in patients with vitiligo. www.clinicaltrialsregister.eu/ctr-search/trial/2010-019994-13/FR/ (accessed 04.2013).
158. IRCT138808212704N1. 308-nm excimer laser plus topical calcipotriol in the treatment of vitiligo. www.irct.ir/searchresult.php?keyword=vitiligo&id=2704&field=g&number=1&prt=13&total=6&m=1 (accessed 04.2013 ).
159. IRCT138904081159N6. Comparative evaluation of efficacy of dermabrasion alone, injection of melanocyte suspension and autologous melanocyte suspension transfer in the treatment of vitiligo. www.irct.ir/searchresult.php?keyword=vitiligo&id=1159&number=6&field=c&prt=6&total=10&m=1 (accessed 10.2013).
160. IRCT201107317160N1. Evaluation of the efficacy of topical ethyl vanillate in enhancing the effect of phothotherapy against vitilligo. www.irct.ir/searchresult.php?keyword=vanillate&id=7160&number=1&field=g&prt=1&total=1&m=1 (accessed10.2013).
161. IRCT201108017160N3. Evaluation of efficay of topical tetracycline in enhancing the effect of phototherapy against vitiligo. www.irct.ir/searchresult.php?keyword=vitiligo&id=7160&field=c&number=3&prt=2&total=10&m=1 (accessed 10.2013).
162. IRCT201201025069N5. Efficacy of Nigella Sativa oil and fish oil in vitiligo patients in Iran. apps.who.int/trialsearch/trial.aspx?trialid=IRCT201201025069N5 (accessed 04.2013).
163. IRCT201203108567N1. Effects of transplantation (non-cultured autologous melanocytes) bulge region, dermal papilla and outer root sheet in stable vitiligo plaques. www.irct.ir/searchresult.php?id=8567&number=1 (accessed 04.2013).
164. IRCT201205029618N1. Formulation and clinical trial of a traditional dosage form for skin depigmentation and comparison to a marketed preparation in two groups of patients suffering from vitiligo. www.who.int/trialsearch/trial.aspx?trialid=IRCT201205029618N1 (accessed 04.2013).
165. IRCT201208144269N4. Comparative efficacy of 0.1%tacrolimus ointment versus 0.005% calcipotriol ointment in perifollicular pigmentation in patients with hand and facial vitiligo. apps.who.int/trialsearch/trial.aspx?trialid=IRCT201208144269N4 (accessed 04.2013 ).
166. IRCT201212059800N3. Evaluation of efficacy of microdermabrasion in association with tacrolimus ointment plus elocome ointment in compare with pimecrolimus ointment plus elocome ointment in patients with vitiligo. www.irct.ir/searchresult.php?keyword=vitiligo&id=9800&number=3&field=c&prt=15&total=6&m=1 (accessed 10.2013).
167. ISRCTN51633881. A prospective within-patient randomised controlled trial of the treatment of vitiligo with the 308-nm laser: A pilot study. www.controlled-trials.com/ISRCTN51633881 (accessed 04.2013).
168. NCT00615355. Efficacy of narrow-band UVB treatment after transplantation of harvested epidermal cells in vitiligo. clinicaltrials.gov/ct2/show/NCT00615355 (accessed 04.2013).
169. NCT00622180. The efficacy of hand NBUVB versus Excilite treatment in vitiligo after minigrafting on the dorsal hands. clinicaltrials.gov/ct2/show/NCT00622180 (accessed 04.2013).
170. NCT00622180. The efficacy of hand-foot narrow-band UVB versus focal 308-nm treatment in inducing repigmentation of vitiligo after minigrafting on the dorsal hands. clinicaltrials.gov/ct2/show/NCT00622180 (accessed 04.2013).
171. NCT01006421. Oral Ginkgo Biloba and narrow band UVB in the treatment of vitiligo: a randomized double-blind placebo controlled trial. clinicaltrials.gov/ct2/show/NCT01006421 (accessed 04.2013).
172. NCT01246921. Effect of fluticasone proprionate 0.05% cream on narrow band UV-B Phototherapy in active vitiligo: a randomised single-blinded controlled trial. clinicaltrials.gov/show/NCT01246921 (accessed 04.2013).
173. NCT1262547. A randomized controlled pilot study to examine the use of micrografting, using a novel grafting technique for the repigmentation of vitiligo. controlled-trials.com/mrct/trial/1343871/vitiligo (accessed 10.2013).
174. NCT01333410. Comparison the efficacy and safety of 0.1% tacrolimus ointment with 0.1% mometasone furoate cream in the treatment of adult vitiligo: A single blinded pilot study. clinicaltrials.gov/show/NCT01333410 (accessed 04.2013).
175. NCT01377077. Autologous punch grafting in vitiligo patients: the effect of punch depth and punch size. clinicaltrials.gov/show/NCT01377077 (accessed 04.2013).
176. NCT01382589. A phase II randomised pilot study to compare the efficacy and safety of subcutaneous, bioresorbable afamelanotide implants and Narrow-Band Ultraviolet B (NB-UVB) light in the treatment of non-segmental vitiligo. clinicaltrials.gov/ct2/show/NCT01382589 (accesssed 04.2013).
177. NCT01419964. Phase III, multicenter, randomized, double-blind, placebo-controlled parallel group study of the efficacy and safety of ACH24 in the treatment of vitiligo. clinicaltrials.gov/ct2/show/NCT01419964 (accessed 04.2013).
178. NCT01430195. Proof of Concept study to compare efficacy and safety of subcutaneous, bioresorbable Afamelanotide implants and Narrow-Band Ultraviolet B (NB-UVB) light versus NB-UVB light alone in the treatment of nonsegmental vitiligo. clinicaltrials.gov/ct2/show/NCT01430195 (accessed 04.2013).
179. NCT01478945. Pilot randomised controlled trial of hand held NB-UVB for the treatment of focal or early vitiligo at home. clinicaltrials.gov/show/NCT01478945?displayxml=true (accessed 04.2013). [: PR-PG-040710177]
180. NCT01511965. Study of applications of autologous epidermal cells in liquid phase in the treatment of vitiligo (Viticell). clinicaltrials.gov/ct2/show/NCT01511965 (accessed 04.2013).
181. NCT01517893. A Phase-II, randomized, placebo-controlled trial of simvastatin in generalizedvitiligo. clinicaltrials.gov/ct2/show/NCT01517893 (accessed 04.2013).
182. NCT01629979. Efficacy and tolerance of transplantation of harvested epidermal cells and narrow-band UVB in vitiligo. clinicaltrials.gov/show/NCT01629979 (accessed 04.2013).
183. NCT01640678. Autologous cell suspension grafting using ReCell in vitiligo and piebaldism patients:a randomized controlled pilot study. clinicaltrials.gov/show/NCT01640678 (accessed 04.2013).
184. NCT01766609. Efficacy and safety of intralesional triamcinolone acetonide in vitiligo: a prospective, double-blind randomized controlled trial. www.clinicaltrials.gov/ct2/show/NCT01766609 (accessed 04.2013).
185. NCT01787695. UVA 1 phototherapy for vitiligo. clinicaltrials.gov/ct2/show/NCT01787695 (accessed 04.2013).
186. NCT01787708. Efficacy of red light in vitiligo: a prospective, single-blind, radomized controlled trial. clinicaltrials.gov/ct2/show/NCT01787708 (accessed 04.2013).
187. NCT01841008. Maintenance treatment of non segmental vitiligo with tacrolimus ointment 0.1% versus control. clinicaltrials.gov/show/NCT01841008 (accessed 10.2013).
188. NCT01923142. Double blind within-subject controlled study of autologous hair follicle outer-root-sheath melanocytes transplantation in the treatment of vitiligo. clinicaltrials.gov/ct2/show/NCT01923142 (accessed 10.2013).
189. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials: The CONSORT statement. JAMA 1996;276(8):637-9. [MEDLINE: 8773637]
190. Behl PN, Bhatia RK. 400 cases of vitiligo: A clinico-therapeutic analysis. Indian Journal of Dermatology 1972;17(2):51-6. [MEDLINE: 5039893]
191. Borderé AC, Lambert J, van Geel N. Current and emerging therapy for the management of vitiligo. Clinical, Cosmetic & Investigational Dermatology 2009;2:15-25. [MEDLINE: 21436965]
192. Bystryn JC. Serum antibodies in vitiligo patients. Clinics in Dermatology 1988;7(2):136-45. [MEDLINE: 2667738]
193. Chan MF, Chua TL. The effectiveness of therapeutic interventions on quality of life for vitiligo patients: a systematic review. International Journal of Nursing Practice 2012;18(4):396-405. [MEDLINE: 22845640]
194. Cui J, Arita Y, Bystryn JC. Characterization of vitiligo antigens. Pigment Cell Research 1995;8(1):53-9. [MEDLINE: 7792255]
195. Eleftheriadou V, Thomas KS, Whitton ME, Batchelor JM, Ravenscroft JC. Which outcomes should we measure in vitiligo? Results of a systematic review and a survey among patients and clinicians on outcomes in vitiligo trials. British Journal of Dermatology 2012;167(4):804-14. [MEDLINE: 22591025]
196. Ezzedine K, Diallo A, Léauté-Labrèze, C, Mossalayi D, Gautier Y, Bouchtnel S, et al. Multivariate analysis of factors associated with early-onset segmental and non-segmental vitiligo: a prospective observational study of 213 patients. British Journal of Dermatology 2011;165(1):44-9. [MEDLINE: 21410675]
197. Ezzedine K, Gauthier Y, Léauté-Labrèze C, Marquez S, Bouchtnel S, Jouary T, et al. Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): A retrospective case series of 19 patients. Journal of the American Academy of Dermatology 2011;65(5):965-71. [MEDLINE: 21616559]
198. Ezzedine K, Diallo A, Léauté-Labrèze C, Seneschal J, Boniface K, Cario-André M, et al. Pre- vs post-pubertal onset of vitiligo: multivariate analysis indicates atopic diasthesis association in pre-pubertal onset vitiligo. British Journal of Dermatology 2012;167(3):490-5. [MEDLINE: 22512840]
199. Ezzedine K, Diallo A, Léauté-Labrèze C, Seneschal J, Mossalayi D, AlGhamdi K, et al. Halo nevi association in nonsegmental vitiligo affects age at onset and depigmentation pattern. Archives of Dermatology 2012;148(4):497-502. [MEDLINE: 22508876]
200. Ezzedine K, Eleftheriadou V, Whitton M, Van Geel N. Vitiligo. Lancet In press.
201. Forschner T, Buchholtz S, Stockfleth E. Current state of vitiligo therapy--evidence-based analysis of the literature. Journal der Deutschen Dermatologischen Gesellschaft 2007;5(6):467-75. [MEDLINE: 17537039]
202. Francis A, Criton S, Shojan A, Philip R. Micropigmentation in vitiligo of lateral lower lip. Journal of Cutaneous & Aesthetic Surgery 2013;6(4):236-7. [PUBMED: 24470724]
203. Gauthier Y, Cario-Andre M, Lepreux S, Pain C, TaÏeb A. Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo. British Journal of Dermatology 2003;148(1):95-101. [MEDLINE: 12534601]
204. Goldstein E, Haberman HF, Menon IA, Pawlowski D. Non-psoralen treatment of vitiligo. Part ll: Less commonly used and experimental therapies. International Journal of Dermatology 1992;31(5):314-9. [MEDLINE: 1587657]
205. González U, Whitton M, Eleftheriadou V, Pinart M, Batchelor J, Leonardi-Bee J. Guidelines for designing and reporting clinical trials in vitiligo. Archives of Dermatology 2011;147(12):1428-36. [MEDLINE: 21844427]
206. Hamzavi IH, Lim HW, Syed ZU. Ultraviolet-based therapy for vitiligo: what's new?. Indian Journal of Dermatology, Venereology & Leprology 2012;78(1):42-8. [PUBMED: 22199059]
207. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
208. Howitz J, Brodthagen H, Schwartz M, Thomsen K. Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark. Archives of Dermatology 1977;113(1):47-52. [MEDLINE: 831622]
209. Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, Bennett DC, et al. NALP1 in vitiligo-associated multiple autoimmune disease. New England Journal of Medicine 2007;356(12):1216-25. [MEDLINE: 17377159]
210. Jin Y, Birlea SA, Fain PR, Gowan K, Riccardi SL, Holland PJ, et al. Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. New England Journal of Medicine 2010;362(18):1686-97. [PUBMED: 20410501]
211. Jin Y, Birlea SA, Fain PR, Ferrara TM, Ben S, Riccardi SL, et al. Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nature Genetics 2012;44(6):676-80. [PUBMED: 22561518]
212. Kim SM, Lee HS, Hann SK. The efficacy of low dose oral corticosteroids in the treatment of vitiligo patients. International Journal of Dermatology 1999;38(7):546-50. [MEDLINE: 10440289]
213. Klaus S, Lerner AB. Vitiligo. Journal of the American Academy of Dermatology 1984;11(5 Pt 2):997-1000. [MEDLINE: 6501614]
214. Krüger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. International Journal of Dermatology 2012;51(10):1206-12. [MEDLINE: 22458952]
215. Kumari J. Vitiligo treated with topical clobetasol propionate. Archives of Dermatology 1984;120(5):631-5. [MEDLINE: 6721525]
216. Leonardi-Bee J, Batta K, O'Brien C, Bath-Hextall FJ. Interventions for infantile haemangiomas (strawberry birthmarks) of the skin. Cochrane Database of Systematic Reviews 2011, Issue 5. [DOI: ]
217. Lerner AB. On the etiology of vitiligo and gray hair. American Journal Medicine 1971;51(2):141-7. [MEDLINE: 5095523]
218. Lerner AB, Nordlund JJ. Vitiligo. What is it? Is it important?. JAMA 1978;239(12):1183-7. [MEDLINE: 628076]
219. Levandowski CB, Mailloux CM, Ferrara TM, Gowan K, Ben S, JIn Y, et al. NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1β processing via the NLRP1 inflammasome. Proceedings ofthe National Academy of Science 2013;110(8):2952-6.
220. Levy LL, Emer JJ. Emotional benefit of cosmetic camouflage in the treatment of facial skin conditions: Personal experience and review. Clinical, Cosmetic & Investigational Dermatology 2012;5:173-82. [MEDLINE: 23152694]
221. Lindhorst Homan MW, de Korte J, Grootenhuis MA, Bos JD, Sprangers MA, Van der Veen JP. Impact of childhood vitiligo on adult life. British Journal of Dermatology 2008;159(4):915-20. [MEDLINE: 18717679]
222. Mulekar SV, Isedeh P. Surgical interventions for vitiligo: an evidence-based review. British Journal of Dermatology 2013;169(Suppl 3):57-66. [PUBMED: 24098901]
223. Njoo MD, Spuls PI, Bos JD, Westerhof W, Bossuyt PM. Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature. Archives of Dermatology 1998;134(12):1532-40. [MEDLINE: 9875190]
224. Ongenae K, Van Geel N, De Schepper S, Naeyaert JM. Effect of vitiligo on self-reported health-related quality of life. British Journal Dermatology 2005;152(6):1165-72. [MEDLINE: 15948977]
225. Pahwa P, Mehta M, Khaitan BK, Sharma VK, Raman M. The psychosocial impact of vitiligo in Indian patients. Indian Journal of Dermatology, Venereology & Leprology 2013;79(5):679-85. [MEDLINE: 23974584]
226. Papadopoulos L, Bor R, Legg C, Hawk JL. Impact of life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology. Clinical & Experimental Dermatology 1998;23(6):243-8. [MEDLINE: 10233617]
227. Papadopoulos L, Bor R, Legg C. Coping with the disfiguring effects of vitiligo: A preliminary investigation into the effects of cognitive-behavioural therapy. British Journal of Medical Psychology 1999;72(Pt 3):385-96. [MEDLINE: 10524722]
228. Park KK, Liao W, Murase JE. A review of monochromatic excimer light in vitiligo. British Journal of Dermatology 2012;167(3):468-78. [PUBMED: 22524428]
229. Parsad D, Dogra S, Kanwar AJ. Quality of life in patients with vitiligo. Health & Quality of Life Outcomes 2003;1:58. [MEDLINE: 14613564]
230. Picardo M, TaÏeb A. Vitiligo. 1. Berlin Heidelberg: Springer, 2010.
231. Porter J, Beuf AH, Nordlund JJ, Lerner AB. Psychological reaction to chronic skin disorders: a study of patients with vitiligo. General Hospital Psychiatry 1979;1(1):73-7. [MEDLINE: 499777]
232. Porter J, Beuf AH, Lerner AB, Nordlund J. Response to cosmetic disfigurement: Patients with vitiligo. Cutis 1987;39(6):493-4. [MEDLINE: 3608575]
233. Porter JR, Beuf AH, Lerner AB, Nordlund JJ. The effect of vitiligo on sexual relationships. Journal of the American Academy of Dermatology 1990;22(2 Pt 1):221-2. [MEDLINE: 2312803]
234. Rezaei N, Gavalas NG, Weetman AP, Kemp EH. Autoimmunity as an aetiological factor in vitiligo. Journal Eurpean Academy Dermatology Venereology 2007;21(7):865-76. [MEDLINE: 17658994]
235. Richmond JM, Frisoli ML, Harris JE. Innate immune mechanisms in vitiligo: danger from within. Current Opinion in Immunology 2013;25(6):676-82. [EMBASE: 2013768733]
236. Schallreuter KU, Bahadoran P, Picardo M, Slominski A, Elassiuty YE, Kemp EH, et al. Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?. Experimental Dermatology 2008;17(2):139-40; discussion 141-60. [MEDLINE: 18205713]
237. Schmid-Ott G, Künsebeck HW, Jecht E, Shimshoni R, Lazaroff I, Schallmayer S, et al. Stigmatization experience, coping and sense of coherence in vitiligo patients. Journal of the European Academy Dermatology & Venereology 2007;21(4):456-61. [MEDLINE: 17373970]
238. Seiter S, Urgel S, Tilgen W, Reinhold U. Use of high-dose methylprednsiolone pulse therapy in patients with progressive and stable vitiligo. International Journal of Dermatology 2000;39(8):624-7. [MEDLINE: 10971735]
239. Silverberg JI, Silverberg NB. Quality of life impairment in children and adolescents with vitiligo. Pediatric Dermatology 2014;31(3):309-18. [MEDLINE: 24304125]
240. Spritz RA. The genetics of generalized vitiligo and associated autoimmune diseases. Pigment Cell Research 2007;20(4):271-8. [MEDLINE: 17630960]
241. Spritz RA. The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma. Genome Medicine 2010;2(10):78. [PUBMED: 20959028]
242. Spritz RA. Modern vitiligo genetics sheds new light on an ancient disease. Journal of Dermatology 2013;40(5):310-8. [PUBMED: 23668538]
243. Szczurko O, Boon HS. A systematic review of natural health product treatment for vitiligo. BMC Dermatology 2008;22(8):2. [MEDLINE: 18498646]
244. Talsania N, Lamb B, Bewley A. Vitiligo is more than skin deep: A survey of members of the Vitiligo Society. Clinical & Experimental Dermatology 2010;35(7):736-9. [MEDLINE: 20015281]
245. Taïeb A, Picardo M, VETF Members. The definition and assessment of vitiligo: A consensus report of the Vitiligo European Task Force. Pigment Cell Research 2007;20(1):27-35. [MEDLINE: 17250545]
246. Taieb A. Vitiligo as an inflammatory skin disorder: A therapeutic perspective. Pigment Cell & Melanoma Research 2012;25(1):9-13. [MEDLINE: 22099450]
247. Teulings HE, Overkamp M, Ceylan E, Nieuweboer-Krobotova L, Bos JD, Nijsten T, et al. Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners. British Journal of Dermatology 2013;168(1):162-71. [PUBMED: 23136900]
248. van Geel N, Speeckaert R, De Wolf J, Bracke S, Chevolet I, Brochez L, et al. Clinical significance of Koebner phenomenon in vitiligo. British Journal of Dermatology 2012;167(5):1017-24. [MEDLINE: 22950415]
249. Vrijman C, Homan ML, Limpens J, van der Veen W, Wolkerstorfer A, Terwee CB, et al. Measurement properties of outcome measures for vitiligo: A systematic review. Archives of Dermatology 2012;17:1-8. [DOI: ; PUBMED: 22986764]
250. Westerhof W, d'Ischia M. Vitiligo puzzle: The pieces fall in place. Pigment Cell Research 2007;20(5):345-59. [MEDLINE: 17850508]
251. Wu Y, Liu Y-B, Zhu X, Dong G-H, Gu X-C, Gao X-H. Efficacy and safety of tacrolimus and pimecrolimus ointment on vitiligo: A systematic review. Chinese Journal of Evidence-Based Medicine 2009;9:788-95.
252. Xiao BH, Wu Y, Sun Y, Chen HD, Gao XH. Treatment of vitiligo with NB-UVB: A systematic review. Journal of Dematological Treatment 2014 Aug 26 [Epub ahead of print].
253. Whitton ME, Ashcroft DM, Barrett CW, Gonzalez U. Interventions for vitiligo. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: ]
254. Whitton ME, Batchelor J, Lushey C, Leonardi-Bee J, González U. Interventions for vitiligo. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: ]